Related Experiment Video
Updated: May 13, 2026
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
The Use of Thrombectomy during Primary Percutaneous Coronary Intervention: Resurrecting an Old Concept in
Zahir Satti1, Muntaser Omari1, Bilal Bawamia1
1Cardiothoracic Department, Freeman Hospital, Freeman Road, Newcastle upon Tyne NE7 7DN, UK.
Insights
Optimal reperfusion after primary percutaneous coronary intervention (pPCI) requires addressing microcirculation issues, not just epicardial flow. Thrombus aspiration trials show no routine benefit, necessitating further research into its role in STEMI.
Area of Science:
- Cardiology
- Interventional Cardiology
- Biomedical Engineering
Background:
- Optimal myocardial reperfusion in primary percutaneous coronary intervention (pPCI) extends beyond epicardial flow restoration.
- Microcirculatory function is critical, with thrombus burden and distal embolization impacting outcomes in ST-segment elevation myocardial infarction (STEMI).
- The no-reflow phenomenon (NRP) is linked to adverse clinical outcomes.
Purpose of the Study:
- To review the limitations of current thrombectomy devices in pPCI.
- To explore the relationship between thrombus burden, microcirculation, and clinical outcomes.
- To provide insights into future research directions for adjunctive thrombectomy in STEMI.
Main Methods:
- Literature review of existing trials and data on thrombectomy during pPCI.
- Analysis of studies investigating microcirculatory reperfusion and its predictors.
- Evaluation of clinical endpoints from randomized controlled trials.
Main Results:
- Prior trials of routine thrombectomy during pPCI have not demonstrated improved clinical endpoints compared to pPCI alone.
- Distal embolization and the no-reflow phenomenon are independent predictors of mortality and worse outcomes in STEMI patients.
- The efficacy of thrombectomy in improving microcirculatory reperfusion remains an area of active investigation.
Conclusions:
- Routine use of adjunctive thrombectomy in pPCI is not supported by current evidence.
- Further investigation is needed to identify specific patient subgroups or refined techniques where thrombectomy may improve microcirculatory reperfusion and clinical outcomes in STEMI.
- Future trials should focus on optimizing reperfusion at the microcirculatory level.
Abstract:
Optimal myocardial reperfusion during primary percutaneous coronary intervention (pPCI) is increasingly recognized to be beyond restoring epicardial coronary flow. Both invasive and non-invasive tools have highlighted the limitation of using this metric, and more efforts are focused towards achieving optimal reperfusion at the level of the microcirculation. Recent data highlighted the close relationship between thrombus burden and impaired microcirculation in patients presenting with ST-segment elevation myocardial infarction (STEMI). Moreover, distal embolization was an independent predictor of mortality in patients with STEMI. Likewise, the development of no-reflow phenomenon has been directly linked with worse clinical outcomes. Adjunctive thrombus aspiration during pPCI is intuitively intended to remove atherothrombotic material to mitigate the risk of distal embolization and the no-reflow phenomenon (NRP). However, prior trials on the use of thrombectomy during pPCI did not support its routine use, with comparable clinical endpoints to patients who underwent PCI alone. This article aims to review the existing literature highlighting the limitation on the use of thrombectomy and provide future insights into trials investigating the role of thrombectomy in contemporary pPCI.
Related Concept Videos
01:27Peripheral Artery Disease III: Interprofessional Care
01:29Venous Thrombosis III: Interprofessional Care
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care